| Jennifer B Schwartz, MD | |
|
1101 Beacon St, 4 East, Brookline, MA 02446-5587 | |
| (617) 396-8005 | |
| (617) 396-8015 |
| Full Name | Jennifer B Schwartz |
|---|---|
| Gender | Female |
| Speciality | Family Medicine - Sports Medicine |
| Location | 1101 Beacon St, Brookline, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700045663 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | 246750 (Massachusetts) | Primary |
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194765438 PECOS PAC ID: 4486567104 Enrollment ID: O20031204000918 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
| Entity Name | Newton-wellesley Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538191218 PECOS PAC ID: 0244133494 Enrollment ID: O20040127001012 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
| Entity Name | Harvard Medical Faculty Phys At Beth Israel Deaconess Med Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972544591 PECOS PAC ID: 4486567104 Enrollment ID: O20040315000691 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
| Entity Name | Medical Care Of Boston Management Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437196359 PECOS PAC ID: 6800787714 Enrollment ID: O20040322000778 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer B Schwartz, MD 1101 Beacon St, 4 East, Brookline, MA 02446-5587 Ph: (617) 396-8005 | Jennifer B Schwartz, MD 1101 Beacon St, 4 East, Brookline, MA 02446-5587 Ph: (617) 396-8005 |
News Archive
Cascade Technologies, Inc. announced today that its wholly owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule.
According to two studies sponsored by drugmaker Pfizer and published in the New England Journal of Medicine on Wednesday, the antiretroviral drug maraviroc, which is sold as Selzentry by Pfizer, might help control viral loads among HIV-positive people who have shown resistance to other treatments, Reuters reports.
Anyone who works in a hospital will tell you some workplace practices have not kept up with modern technological advances. Australian nurse and mother-of-two Beth Wozniak's new Scrubit app is revolutionizing the surgical theater and giving patients peace of mind that their surgeon will be equipped with the tools needed to do their job.
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
A new drug to treat hepatitis C that costs $1,000 a pill has caused rising concern among insurers and state Medicaid programs. It has now also spurred interest from Democratic congressmen whose queries about the drug prompted a sell-off in biotechnology stocks on Friday. Three Democratic members of the House Energy and Commerce Committee have demanded that Gilead Sciences, the developer, justify the price of its drug, which is called Sovaldi (Pollack, 3/21).
› Verified 6 days ago
Kendra Nicole Maher, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 1180 Beacon St Ste 1a, Brookline, MA 02446 Phone: 617-396-8005 | |
Amy Pearsall, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 344 Harvard St, 3, Brookline, MA 02446 Phone: 646-483-8709 | |
Emily P.r. Nields, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Brookline Pl, Brookline, MA 02445 Phone: 317-355-2727 | |
Ronak Vatsal Shah, Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1285 Beacon St, Brookline, MA 02446 Phone: 617-751-6205 | |
Robyn Lee Reese, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Brookline Place Suite 230, Brookline, MA 02445 Phone: 617-278-8166 | |
Chander Kumar Khatri, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1285 Beacon St, Partners Urgent Care, Brookline, MA 02446 Phone: 617-751-6205 | |
Youko G Yeracaris, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 32 Kent St, Ste 108, Brookline, MA 02445 Phone: 617-731-5100 |